Intercept Pharmaceuticals (ICPT)
$96.65 3.01 (3.02%)
17:14 EST ICPT Stock Quote Delayed 15 Minutes
Previous Close $96.65
Market Cap 2.86B
PE Ratio -6.91
Volume (Avg. Vol.) 574,200
Day's Range 95.91 - 100.11
52-Week Range 56.76 - 131.87
Dividend & Yield N/A (N/A)
ICPT Stock Predictions, Articles, and Intercept Pharmaceuticals News
- From InvestorPlace
- From the Web
As markets continue to hit all-time highs, consider taking profits in these stocks to sell before their companies report slowing growth.
Eli Lilly, Alexion and AbbVie are just some of the top healthcare stocks to buy here, now that disappointing news has driven them to cheap prices.
The economy may be slowing but these small-cap stocks have plenty of momentum. Keep these 7 names on your radar.
Canopy Growth, CVS Health, Intercept Pharmaceuticals, Rite Aid and UnitedHealth are our top stock trades to watch for Friday.
Apple, Facebook, Gold, Weight Watchers and Intercept Pharmaceuticals are setting up to be our top stock trades for Wednesday.
Intercept Pharmaceuticals news concerning the results from a recent Phase 3 clinical trial have ICPT stock heading higher today.
With the worst of the market turbulence hopefully in the rear-view mirror, these look like the best stocks to buy as the year winds down.
These 20 stocks are facing heavy pressure from short sellers - which could lead to epic gains if those traders are proven wrong.
After the market's rout, biotech stocks offer a huge value right now. Here are 5 that offer the best opportunities for investors.
Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.
Intercept Pharmaceuticals (ICPT) stock took a hit on Tuesday following the release of a drug warning concerning its Ocaliva.
The following stocks were moving the Manufacturing sector today.
Biogen (BIIB), Intercept (ICPT) and Gilead Sciences (GILD) are all thought to be among biotech's best-looking stocks right now. Two out of three ain't bad.
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
This week, the ratings of 19 Biotechnology stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100..
Investors in Intercept Pharmaceuticals Inc (ICPT) saw new options become available today, for the March 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ICPT options chain for the new March 6th contracts and identified one put and one call contract of particular interest.
Investors in Intercept Pharmaceuticals Inc (ICPT) saw new options become available this week, for the September 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 239 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration..
Navellier RatingsPowered by Portfolio Grader